Rationale and clinical implication of combined chemotherapy with cisplatin and oestrogen in prostate cancer: primary evidence based on methylation analysis of oestrogen receptor-alpha.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples